European Equities Traded in the US as American Depositary Lower in Tuesday Trading

MT Newswires Live12-11

European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 0.38% to 1,348.76 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications company VEON (VEON) and biopharmaceutical company Cellectis (CLLS), which rose 1.9% and 1.5% respectively. They were followed by medical device maker EDAP (EDAP) and financial services company Banco Santander (SAN), which were up 3.6% and 0.5% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and accommodations booking company trivago (TRVG), which fell 5.8% and 4.7% respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and internet browser company Opera (OPRA), which lost 4.4% and 3.2% respectively.

From the UK and Ireland, the gainers were led by cruise line operator Carnival (CUK) and software firm Endava (DAVA), which increased 3.4% and 0.5% respectively. They were followed by BP oil and gas company (BP) and financial services company HSBC (HSBC), which rose 0.5% and 0.2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and biotech firm Trinity Biotech (TRIB), which tumbled 16.4% and 13.1% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Bicycle Therapeutics (BCYC), which were down 3.6% and 2.1% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment